Literature DB >> 28689991

Ubiquitin phosphorylated at Ser57 hyper-activates parkin.

Susanna George1, Sabrina M Wang1, Yumin Bi1, Margot Treidlinger2, Kathryn R Barber1, Gary S Shaw3, Patrick O'Donoghue4.   

Abstract

Malfunction of the ubiquitin (Ub) E3 ligase, parkin, leads to defects in mitophagy and protein quality control linked to Parkinson's disease. Parkin activity is stimulated by phosphorylation of Ub at Ser65 (pUbS65). Since the upstream kinase is only known for Ser65 (PINK1), the biochemical function of other phosphorylation sites on Ub remain largely unknown. We used fluorescently labelled and site-specifically phosphorylated Ub substrates to quantitatively relate the position and stoichiometry of Ub phosphorylation to parkin activation. Fluorescence measurements show that pUbS65-stimulated parkin is 5-fold more active than auto-inhibited and un-stimulated parkin, which catalyzes a basal level of auto-ubiquitination. We consistently observed a low but detectable level of parkin activity with pUbS12. Strikingly, pUbS57 hyper-activates parkin, and our data demonstrate that parkin is able to selectively synthesize poly-pUbS57 chains, even when 90% of the Ub in the reaction is un-phosphorylated. We further found that parkin ubiquitinates its physiological substrate Miro-1 with chains solely composed of pUbS65 and more efficiently with pUbS57 chains. Parkin hyper-activation by pUbS57 demonstrates the first PINK1-independent route to active parkin, revealing the roles of multiple ubiquitin phosphorylation sites in governing parkin stimulation and catalytic activity. This article is part of a Special Issue entitled "Biochemistry of Synthetic Biology - Recent Developments" Guest Editor: Dr. Ilka Heinemann and Dr. Patrick O'Donoghue.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  E3 ligase; Genetic code expansion; Parkinson's disease; Post-translational modification; Refolding; SepRS; Ubiquitin; tRNA(Sep)

Mesh:

Substances:

Year:  2017        PMID: 28689991     DOI: 10.1016/j.bbagen.2017.06.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gen Subj        ISSN: 0304-4165            Impact factor:   3.770


  8 in total

Review 1.  The Role of PTEN-L in Modulating PINK1-Parkin-Mediated Mitophagy.

Authors:  Mohamed A Eldeeb; Mansoore Esmaili; Marwa Hassan; Mohamed A Ragheb
Journal:  Neurotox Res       Date:  2022-06-14       Impact factor: 3.978

Review 2.  The Long and the Short of PTEN in the Regulation of Mitophagy.

Authors:  Liming Wang; Guang Lu; Han-Ming Shen
Journal:  Front Cell Dev Biol       Date:  2020-05-13

3.  Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop.

Authors:  François Mouton-Liger; Thibault Rosazza; Julia Sepulveda-Diaz; Amélie Ieang; Sidi-Mohamed Hassoun; Emilie Claire; Graziella Mangone; Alexis Brice; Patrick P Michel; Jean-Christophe Corvol; Olga Corti
Journal:  Glia       Date:  2018-04-17       Impact factor: 7.452

Review 4.  The role of mitophagy in innate immune responses triggered by mitochondrial stress.

Authors:  Yinjuan Song; Yang Zhou; Xiangmei Zhou
Journal:  Cell Commun Signal       Date:  2020-11-25       Impact factor: 5.712

5.  Antibody for Serine 65 Phosphorylated Ubiquitin Identifies PLK1-Mediated Phosphorylation of Mitotic Proteins and APC1.

Authors:  Guy Mann; Prasad Sulkshane; Pradeep Sadhu; Tamar Ziv; Michael H Glickman; Ashraf Brik
Journal:  Molecules       Date:  2022-07-29       Impact factor: 4.927

Review 6.  Regulation of ubiquitin and ubiquitin-like modifiers by phosphorylation.

Authors:  Nathaniel L Hepowit; Carl-Christian Kolbe; Sarah R Zelle; Eicke Latz; Jason A MacGurn
Journal:  FEBS J       Date:  2021-07-21       Impact factor: 5.622

7.  Phosphorylation-Dependent Inhibition of Akt1.

Authors:  Nileeka Balasuriya; McShane McKenna; Xuguang Liu; Shawn S C Li; Patrick O'Donoghue
Journal:  Genes (Basel)       Date:  2018-09-07       Impact factor: 4.096

Review 8.  Modulation of cholinergic activity through lynx prototoxins: Implications for cognition and anxiety regulation.

Authors:  Kristin R Anderson; Katie M Hoffman; Julie M Miwa
Journal:  Neuropharmacology       Date:  2020-04-13       Impact factor: 5.250

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.